Matches in Wikidata for { <http://www.wikidata.org/entity/Q91935713> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q91935713 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91935713 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91935713 description "scientific article published on 15 April 2020" @default.
- Q91935713 description "wetenschappelijk artikel" @default.
- Q91935713 description "наукова стаття, опублікована 15 квітня 2020" @default.
- Q91935713 name "Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma" @default.
- Q91935713 name "Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma" @default.
- Q91935713 type Item @default.
- Q91935713 label "Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma" @default.
- Q91935713 label "Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma" @default.
- Q91935713 prefLabel "Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma" @default.
- Q91935713 prefLabel "Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma" @default.
- Q91935713 P1433 Q91935713-0FE39368-15D0-4817-9955-ECD200C7310E @default.
- Q91935713 P1476 Q91935713-41D063EA-7351-482C-A20F-5709D675461C @default.
- Q91935713 P2093 Q91935713-19F0A7DC-DB16-4653-8176-BA712F021589 @default.
- Q91935713 P2093 Q91935713-3A4ED745-6BEA-4A75-8E1E-5D783634B802 @default.
- Q91935713 P2093 Q91935713-42AB1810-BFCE-4B44-9057-303F5BF5FAF5 @default.
- Q91935713 P2093 Q91935713-8214D331-E6A2-4045-86BC-2982B517272A @default.
- Q91935713 P2093 Q91935713-CE5A65E5-8C7C-43C1-8D5F-3904A51D5E37 @default.
- Q91935713 P31 Q91935713-73414956-F235-4B64-8B30-7C838D7E0C8A @default.
- Q91935713 P356 Q91935713-603155BE-0807-4C16-8AC4-C9EF3A9010FC @default.
- Q91935713 P4510 Q91935713-F4E86A0B-63F7-4A51-8859-8CE194AFE0CF @default.
- Q91935713 P577 Q91935713-5A421017-334B-484E-BCC4-496FC004730B @default.
- Q91935713 P698 Q91935713-6A44D1E6-5E1D-4242-B7B3-F65BC1CF0C1C @default.
- Q91935713 P921 Q91935713-9E02AC7F-6461-43FA-8793-DFA0EC953674 @default.
- Q91935713 P921 Q91935713-A4CE7EF1-8AB9-40EE-B25C-9D69CB86BB34 @default.
- Q91935713 P932 Q91935713-40B60C49-5E4E-460A-A9D0-FF2EC390011C @default.
- Q91935713 P356 S12253-020-00809-Z @default.
- Q91935713 P698 32291570 @default.
- Q91935713 P1433 Q26842743 @default.
- Q91935713 P1476 "Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma" @default.
- Q91935713 P2093 "György Bodoky" @default.
- Q91935713 P2093 "György Rokszin" @default.
- Q91935713 P2093 "Ibolya Fábián" @default.
- Q91935713 P2093 "Lajos Géczi" @default.
- Q91935713 P2093 "László Torday" @default.
- Q91935713 P31 Q13442814 @default.
- Q91935713 P356 "10.1007/S12253-020-00809-Z" @default.
- Q91935713 P4510 Q47607 @default.
- Q91935713 P577 "2020-04-15T00:00:00Z" @default.
- Q91935713 P698 "32291570" @default.
- Q91935713 P921 Q1164529 @default.
- Q91935713 P921 Q19000948 @default.
- Q91935713 P932 "7471136" @default.